MX2018013474A - Acidos carboxilicos para aplicacion en la primera infancia. - Google Patents
Acidos carboxilicos para aplicacion en la primera infancia.Info
- Publication number
- MX2018013474A MX2018013474A MX2018013474A MX2018013474A MX2018013474A MX 2018013474 A MX2018013474 A MX 2018013474A MX 2018013474 A MX2018013474 A MX 2018013474A MX 2018013474 A MX2018013474 A MX 2018013474A MX 2018013474 A MX2018013474 A MX 2018013474A
- Authority
- MX
- Mexico
- Prior art keywords
- application
- carboxylic acids
- early childhood
- patient
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica que comprende como ingrediente activo un ácido carboxílico o una sal farmacéuticamente aceptable del mismo para usar para mejorar la función de barrera cutánea, donde la composición farmacéutica se administra a un lactante. La invención también se refiere a un método para tratar y/o prevenir una enfermedad de la piel en un paciente, el método comprende administrar una cantidad efectiva de un ácido carboxílico o una sal farmacéuticamente aceptable del mismo a un paciente que lo necesita.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169888 | 2016-05-17 | ||
| PCT/EP2017/061835 WO2017198705A1 (en) | 2016-05-17 | 2017-05-17 | Carboxylic acids for early childhood application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018013474A true MX2018013474A (es) | 2019-08-12 |
Family
ID=56014858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018013474A MX2018013474A (es) | 2016-05-17 | 2017-05-17 | Acidos carboxilicos para aplicacion en la primera infancia. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190160030A1 (es) |
| EP (1) | EP3458044A1 (es) |
| JP (1) | JP2019516798A (es) |
| KR (1) | KR20190008236A (es) |
| CN (1) | CN109152755A (es) |
| AU (1) | AU2017266729A1 (es) |
| BR (1) | BR112018072183A2 (es) |
| CA (1) | CA3020558A1 (es) |
| CL (1) | CL2018003269A1 (es) |
| MX (1) | MX2018013474A (es) |
| RU (1) | RU2018143557A (es) |
| SG (1) | SG11201808487UA (es) |
| WO (1) | WO2017198705A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110403914A (zh) * | 2019-06-13 | 2019-11-05 | 兰溪市立顺生物有限公司 | 用于儿童早期应用的羧酸 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0617191D0 (en) * | 2006-08-31 | 2006-10-11 | York Pharma Plc | Improvements in pharmaceutical compositions |
| AU2007214300B2 (en) * | 2007-08-29 | 2009-11-05 | Sunny Pharmtech, Inc. | Method for Ameliorating Pruritus |
| US20130004590A1 (en) * | 2011-06-28 | 2013-01-03 | Lin Connie B | Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
-
2017
- 2017-05-17 MX MX2018013474A patent/MX2018013474A/es unknown
- 2017-05-17 BR BR112018072183-2A patent/BR112018072183A2/pt not_active Application Discontinuation
- 2017-05-17 CA CA3020558A patent/CA3020558A1/en not_active Abandoned
- 2017-05-17 JP JP2019513482A patent/JP2019516798A/ja active Pending
- 2017-05-17 KR KR1020187033156A patent/KR20190008236A/ko unknown
- 2017-05-17 AU AU2017266729A patent/AU2017266729A1/en not_active Abandoned
- 2017-05-17 RU RU2018143557A patent/RU2018143557A/ru not_active Application Discontinuation
- 2017-05-17 EP EP17723140.4A patent/EP3458044A1/en not_active Withdrawn
- 2017-05-17 SG SG11201808487UA patent/SG11201808487UA/en unknown
- 2017-05-17 CN CN201780030745.4A patent/CN109152755A/zh active Pending
- 2017-05-17 US US16/097,746 patent/US20190160030A1/en not_active Abandoned
- 2017-05-17 WO PCT/EP2017/061835 patent/WO2017198705A1/en active Application Filing
-
2018
- 2018-11-16 CL CL2018003269A patent/CL2018003269A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018143557A (ru) | 2020-06-17 |
| BR112018072183A2 (pt) | 2019-02-12 |
| US20190160030A1 (en) | 2019-05-30 |
| AU2017266729A1 (en) | 2018-10-18 |
| JP2019516798A (ja) | 2019-06-20 |
| CA3020558A1 (en) | 2017-11-23 |
| CN109152755A (zh) | 2019-01-04 |
| CL2018003269A1 (es) | 2019-02-22 |
| WO2017198705A1 (en) | 2017-11-23 |
| EP3458044A1 (en) | 2019-03-27 |
| SG11201808487UA (en) | 2018-10-30 |
| KR20190008236A (ko) | 2019-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| JP2014139220A5 (es) | ||
| MX2019012884A (es) | Terapia de combinacion. | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
| BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
| JP2017533972A5 (es) | ||
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| PH12018550210A1 (en) | Oral dosage form with drug composition, barrier layer and drug layer | |
| HRP20201726T1 (hr) | Liječenje valunga i gubitka kostiju izazvanih terapijom uskraćivanja androgena pomoću cis-klomifena | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| MX2016016400A (es) | Formulaciones de oximetazolina estabilizadas y sus usos. | |
| NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
| MX2018013477A (es) | Acidos carboxilicos para tratar/prevenir una enfermedad de la piel. | |
| MX2018013474A (es) | Acidos carboxilicos para aplicacion en la primera infancia. | |
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. | |
| WO2016122288A3 (ko) | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 | |
| MX2018008443A (es) | Composición farmacéutica que comprende nebivolol con tasa de disolución mejorada. | |
| BR112018002433A2 (pt) | composição farmacêutica para tratamento da enxaqueca | |
| AR101227A1 (es) | Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor | |
| EA201592261A1 (ru) | Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой |